Viemed Healthcare, Inc. (VMD)
USD 6.85
(-3.11%)
USD 6.85
(-3.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.5 Million USD | 84.57% |
| 2022 | -16.22 Million USD | 25.9% |
| 2021 | -21.89 Million USD | -10.3% |
| 2020 | -19.84 Million USD | -422.38% |
| 2019 | 6.15 Million USD | 188.09% |
| 2018 | -6.98 Million USD | -8727.16% |
| 2017 | 81 Thousand USD | -96.23% |
| 2016 | 2.15 Million USD | -27.58% |
| 2015 | 2.96 Million USD | 284.24% |
| 2014 | -1.61 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.22 Million USD | 188.8% |
| 2024 Q2 | 3.66 Million USD | 64.76% |
| 2023 Q2 | 6.11 Million USD | 126.6% |
| 2023 Q3 | 821 Thousand USD | -86.57% |
| 2023 FY | -2.5 Million USD | 84.57% |
| 2023 Q1 | -22.98 Million USD | -41.71% |
| 2023 Q4 | -2.5 Million USD | -404.77% |
| 2022 Q4 | -16.22 Million USD | 2.88% |
| 2022 FY | -16.22 Million USD | 25.9% |
| 2022 Q1 | -23.34 Million USD | -6.62% |
| 2022 Q2 | -16.59 Million USD | 28.9% |
| 2022 Q3 | -16.7 Million USD | -0.64% |
| 2021 Q3 | -19.29 Million USD | 14.43% |
| 2021 Q4 | -21.89 Million USD | -13.43% |
| 2021 FY | -21.89 Million USD | -10.3% |
| 2021 Q1 | -21.48 Million USD | -8.23% |
| 2021 Q2 | -22.55 Million USD | -5.0% |
| 2020 FY | -19.84 Million USD | -422.38% |
| 2020 Q4 | -19.84 Million USD | -3.57% |
| 2020 Q3 | -19.16 Million USD | -34.97% |
| 2020 Q2 | -14.19 Million USD | -237.76% |
| 2020 Q1 | 10.3 Million USD | 67.4% |
| 2019 Q1 | -256 Thousand USD | 96.34% |
| 2019 Q4 | 6.15 Million USD | -29.68% |
| 2019 Q2 | 6.65 Million USD | 2698.83% |
| 2019 Q3 | 8.75 Million USD | 31.58% |
| 2019 FY | 6.15 Million USD | 188.09% |
| 2018 Q2 | -2.55 Million USD | -233.13% |
| 2018 FY | -6.98 Million USD | -8727.16% |
| 2018 Q1 | 1.92 Million USD | 2270.37% |
| 2018 Q3 | -4.8 Million USD | -88.15% |
| 2018 Q4 | -6.98 Million USD | -45.31% |
| 2017 Q3 | -6.12 Million USD | 0.0% |
| 2017 Q1 | 4.33 Million USD | 447.12% |
| 2017 FY | 81 Thousand USD | -96.23% |
| 2017 Q4 | 81 Thousand USD | 101.32% |
| 2016 Q4 | -1.25 Million USD | 0.0% |
| 2016 FY | 2.15 Million USD | -27.58% |
| 2015 FY | 2.96 Million USD | 284.24% |
| 2014 FY | -1.61 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 109.239% |
| BrainsWay Ltd. | -10.32 Million USD | 75.755% |
| Cerus Corporation | 84.35 Million USD | 102.966% |
| Envoy Medical, Inc. | -3.81 Million USD | 34.396% |
| electroCore, Inc. | -9.95 Million USD | 74.866% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 51.178% |
| IceCure Medical Ltd | -9.93 Million USD | 74.812% |
| Inogen, Inc. | -103.56 Million USD | 97.584% |
| OrthoPediatrics Corp. | -9.26 Million USD | 73.0% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 31.279% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 80.895% |
| MaxCyte, Inc. | -27.76 Million USD | 90.988% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 51.302% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -334.574% |
| Orthofix Medical Inc. | 96.44 Million USD | 102.594% |
| PAVmed Inc | 29.08 Million USD | 108.603% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 85.229% |
| RxSight, Inc. | -6.68 Million USD | 62.543% |
| Sight Sciences, Inc. | -102.71 Million USD | 97.564% |
| SI-BONE, Inc. | 5.72 Million USD | 143.736% |
| TELA Bio, Inc. | -3.94 Million USD | 36.639% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 104.365% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 810.833% |
| Acutus Medical, Inc. | 12.27 Million USD | 120.377% |
| Talis Biomedical Corporation | -57.06 Million USD | 95.615% |
| Spectral AI, Inc. | -3.5 Million USD | 28.531% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 94.79% |
| CVRx, Inc. | -59.95 Million USD | 95.827% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 226.106% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 295.841% |
| Bioventus Inc. | 372.51 Million USD | 100.672% |
| Venus Concept Inc. | 74.3 Million USD | 103.368% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 75.426% |
| LivaNova PLC | 62.53 Million USD | 104.001% |
| 908 Devices Inc. | -115.09 Million USD | 97.826% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.78% |
| Nemaura Medical Inc. | 9.92 Million USD | 125.21% |
| NeuroPace, Inc. | 54.33 Million USD | 104.605% |
| LENSAR, Inc. | -18.31 Million USD | 86.336% |
| Apyx Medical Corporation | -5.15 Million USD | 51.424% |
| Cutera, Inc. | 288.3 Million USD | 100.868% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 133.295% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1055.012% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 94.291% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 72.8% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.178% |
| Axonics, Inc. | -77.19 Million USD | 96.759% |
| Outset Medical, Inc. | 67.67 Million USD | 103.697% |
| IRIDEX Corporation | -4.28 Million USD | 41.648% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.594% |
| IRadimed Corporation | -47.71 Million USD | 94.757% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 17.312% |
| INVO Bioscience, Inc. | 8.45 Million USD | 129.607% |
| Telesis Bio, Inc. | 32.63 Million USD | 107.667% |
| Varex Imaging Corporation | 316.9 Million USD | 100.79% |
| Quipt Home Medical Corp. | 81.73 Million USD | 103.061% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 10.06% |
| Pulmonx Corporation | -42.36 Million USD | 94.093% |
| Dynatronics Corporation | 6.2 Million USD | 140.331% |
| Modular Medical, Inc. | -8.04 Million USD | 68.887% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 41.77% |
| Semler Scientific, Inc. | -57.13 Million USD | 95.62% |
| InMode Ltd. | -135.39 Million USD | 98.152% |
| Bruker Corporation | 891.3 Million USD | 100.281% |
| Cytosorbents Corporation | 4.18 Million USD | 159.831% |
| DexCom, Inc. | 2.02 Billion USD | 100.123% |
| Align Technology, Inc. | -840.47 Million USD | 99.702% |
| Viveve Medical, Inc. | -13.81 Million USD | 81.886% |
| ZimVie Inc. | 450.41 Million USD | 100.556% |
| Movano Inc. | -5.86 Million USD | 57.345% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 98.139% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -334.574% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 226.106% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.701% |
| Profound Medical Corp. | -18.17 Million USD | 86.236% |
| Insulet Corporation | 798.1 Million USD | 100.314% |
| enVVeno Medical Corporation | -2.21 Million USD | -12.81% |
| Surmodics, Inc. | -12.01 Million USD | 79.173% |
| iCAD, Inc. | -21.2 Million USD | 88.202% |
| Nuwellis, Inc. | -2.81 Million USD | 11.24% |
| Biotricity, Inc. | 23.09 Million USD | 110.835% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 102.672% |
| Aethlon Medical, Inc. | -4.5 Million USD | 44.418% |
| InspireMD, Inc. | -8.04 Million USD | 68.898% |
| PAVmed Inc. | 29.08 Million USD | 108.603% |
| BIOLASE, Inc. | 11.34 Million USD | 122.057% |
| Beyond Air, Inc. | 6.22 Million USD | 140.169% |
| FONAR Corporation | -14.66 Million USD | 82.938% |
| AxoGen, Inc. | 32.26 Million USD | 107.755% |
| Vivani Medical, Inc. | 42 Thousand USD | 6057.457% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 76.523% |
| Inari Medical, Inc. | -7.16 Million USD | 65.059% |
| UFP Technologies, Inc. | 40.77 Million USD | 106.137% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 181.539% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 47.559% |
| Tenon Medical, Inc. | -1.25 Million USD | -99.373% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 67.103% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 79.02% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.113% |
| Sintx Technologies, Inc. | 905 Thousand USD | 376.479% |
| NanoVibronix, Inc. | -3.27 Million USD | 23.669% |
| Quanterix Corporation | -132.95 Million USD | 98.118% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 10.06% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 88.812% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.332% |
| TransMedics Group, Inc. | 121.13 Million USD | 102.066% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 90.443% |
| NeuroMetrix, Inc. | -1.49 Million USD | -67.808% |
| Hyperfine, Inc. | -75.61 Million USD | 96.691% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 101.644% |
| Biomerica, Inc. | -3.38 Million USD | 26.082% |
| Bone Biologics Corporation | -3.02 Million USD | 17.328% |
| AVITA Medical, Inc. | -26.23 Million USD | 90.461% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -36.103% |
| Silk Road Medical, Inc | 64.42 Million USD | 103.884% |